Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Aromatase inhibitors in breast cancer treatment studied
October 6th, 2005
The role of aromatase inhibitors in breast cancer treatment was studied by investigators in Scotland recently. Reporting in the British Journal of Cancer, investigators stated, "Primarily, the role of the aromatase inhibitors has been investigated in postmenopausal women with breast cancer, although it is also now being assessed in premenopausal patients following ovarian ablation/suppression. Aromatase inhibitors markedly suppress endogenous estrogens without directly interacting with estrogen receptors, and thus have a different mechanism of action to the antiestrogen, tamoxifen." Carpenter and Miller, University of Edinburgh explained,...
Source: Women's Health Weekly (2005-10-06)
|
